News

Apollo Endosurgery raises $50M to pay debt for flagging Lap-Band

Apollo Endosurgery has raised $50 million from private equity investor Athyrium Capital Management mostly to repay debt it accrued when it acquired the Lap-Band from Allergan in December 2013 for up to $110 million. As part of that deal, Apollo also gained the intra-gastric balloon system Orbera, which isn't approved in the U.S.

Consumer diagnostics player 23andMe officially pivots to add drug discovery

23andMe has brought in the former EVP of research and early development from Genentech, Richard Scheller, as CSO and head of a newly created therapeutics group. The move seems likely to be a precursor to a major cash infusion.

Apple's ResearchKit is off to a rollicking start

People are hungry to participate in the first 5 iPhone-based studies enabled by Apple's ResearchKit. More than 19,000 participants have signed on within the first 24 hours of the mobile medical app platform's debut.

LifeMap CEO: Apple's ResearchKit 'unshackles science from brick-and-mortar constraints'

The CEO of LifeMap Solutions provided FierceMedicalDevices with further details about its Asthma Help app and study in collaboration with Mount Sinai Hospital, which leverages Apple's new ResearchKit platform for creating mobile health apps. Using data gathered via the iPhone, the study aims to find correlations between individual behavior and asthma symptoms, said LifeMap CEO Corey Bridges during the interview.

Scientists tout positive results for Alzheimer's ultrasound therapy in mice

As scientists home in on innovative technology to treat neurodegenerative conditions such as Alzheimer's, a new study shows that ultrasound therapy could help reduce symptoms associated with the disease in mice.

Medtronic prioritizes product development post-Covidien deal close

A little more than a month after Medtronic closed its $49.9 billion purchase of Covidien, the combined company is forging ahead with ambitious plans for growth. And as Medtronic's chief integration officer, Geoff Martha, told FierceMedicalDevices, the company's "first and foremost strategy" involves developing new devices to support innovative therapies, ultimately cutting costs and making healthcare more efficient.

Startup raises $3.9M to market device-app combo to calm panic disorder

Palo Alto Health Sciences has raised $3.9 million out of a proposed $7.1 million financing, according to an SEC filing. The startup will use the cash to back its FDA-cleared, at-home system to treat panic disorders.

Study tracking outcomes of TAVR patients finds overall one-year death rate to be 23.7%

A study tracking patients who received transcatheter aortic valve replacement (TAVR) cardiology devices found that they have an overall one-year death rate of 23.7%.

Brain-controlled, robotic prosthetic hand comes closer to simulating reality

One of the latest in a series of rapid advances in prosthetics and mobility devices is a more natural prosthetic hand from Ottobock that uses electrical signals originating in the brain to create movement.

CMS opposition to unique device identification threatens the initiative

The federal agency in charge of running Medicare opposes the integration of unique device identification into insurance claims data, putting it at odds with the FDA and most of the medical community.

Med tech moves in on Georgia: Varian, MiMedix to expand with up to 250 new jobs

Med tech jobs are springing up in Georgia. Just recently, Varian Medical Systems said it would add up to 100 technical jobs to its Atlanta-based operations, while MiMedix is slated to increase its employee count at its Marietta, GA, headquarters by up to 150.

J&J's DePuy Synthes recalls orthopedic surgical tool, but not ready to replace

Johnson & Johnson's DePuy Synthes issued a recall last month for 1,500 inserters of titanium elastic nails distributed in the U.S., which the FDA has just disclosed. The warning was given because the inserter is prone to mechanical failure during surgery such as breakage in the main shaft, a jam in the inserter or breakage of the crossbar.

Olympus asked FDA to loosen its belt on cleaning guidelines for endoscope devices

Olympus is facing more pushback over endoscopes tied to drug-resistant superbug outbreaks at U.S. hospitals, as new reports show the company asked the FDA to soften its guidelines on cleaning procedures for the products.

Startup gets FDA nod for device to deter severe GERD condition

The FDA has cleared a neck-worn device to reduce the symptoms of laryngopharyngeal reflux. That condition occurs once gastroesophageal reflux disease (GERD) is so severe that stomach acid travels up the esophagus and into the throat.

Texas Medical Center adds 20+ device companies to its incubator

Houston is synonymous with oil and gas, but the inaugural class of the Texas Medical Center's TMCx accelerator attests to the city's med tech ambitions. Essentially, all of the 22 startups are in the device or health IT arena. There isn't a pure-play drug developer in the mix.

Merck Serono, Illumina partner in the latest universal next-gen cancer diagnostic deal

Cancer diagnostics has long been defined by the aim of providing "personalized" and "precision" medicine to patients. But now the buzzword of the moment seems to be trending more toward "universal"--as the industry strives for an all-encompassing test that will mete out the best possible individual treatment protocols based on genomic data.

English team develops robot for stroke rehabilitation

Researchers at England's University of Hertfordshire have designed a robotic glove to help victims of stroke rehabilitate.

Sequenom's noninvasive prenatal diagnostic uncovers signs of cancer in 40 women

Sequenom has long depended on its noninvasive prenatal diagnostic test to drive growth and fuel expansion. But now, the company unveiled new results which show that its MaterniT21 test can detect signs of cancer in pregnant women, a potential game-changer as Sequenom looks to expand its market reach.

Startup gets $9.3M Series B for high-performance ultraviolet LED disinfection

RayVio is promising a high-performance, low-cost ultraviolet LED system that can be used to aid in disinfection across industrial, commercial and consumer sectors. To support this ambition, the startup has raised a $9.3 million Series B financing.

Drawing blood glucose sensors on your body: The future of diagnostics?

It's one of those ideas that sounds wacky and way out there, but researchers at the University of California, San Diego, have apparently found a way to draw a blood glucose sensor onto a patient's skin using regular ballpoint pen.